DK332086D0 - Fremgangsmaade til rensning af faktor viii.c og farmaceutisk middel indeholdende faktor viii.c - Google Patents

Fremgangsmaade til rensning af faktor viii.c og farmaceutisk middel indeholdende faktor viii.c

Info

Publication number
DK332086D0
DK332086D0 DK332086A DK332086A DK332086D0 DK 332086 D0 DK332086 D0 DK 332086D0 DK 332086 A DK332086 A DK 332086A DK 332086 A DK332086 A DK 332086A DK 332086 D0 DK332086 D0 DK 332086D0
Authority
DK
Denmark
Prior art keywords
factor viii
procedure
pharmaceutical composition
composition containing
cleaning
Prior art date
Application number
DK332086A
Other languages
English (en)
Other versions
DK332086A (da
Inventor
David L Farb
Ricardo H Landaburu
Original Assignee
Armour Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Armour Pharma filed Critical Armour Pharma
Publication of DK332086D0 publication Critical patent/DK332086D0/da
Publication of DK332086A publication Critical patent/DK332086A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK332086A 1985-07-11 1986-07-11 Fremgangsmaade til rensning af faktor viii.c og farmaceutisk middel indeholdende faktor viii.c DK332086A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/753,822 US4758657A (en) 1985-07-11 1985-07-11 Method of purifying Factor VIII:C

Publications (2)

Publication Number Publication Date
DK332086D0 true DK332086D0 (da) 1986-07-11
DK332086A DK332086A (da) 1987-01-12

Family

ID=25032302

Family Applications (1)

Application Number Title Priority Date Filing Date
DK332086A DK332086A (da) 1985-07-11 1986-07-11 Fremgangsmaade til rensning af faktor viii.c og farmaceutisk middel indeholdende faktor viii.c

Country Status (6)

Country Link
US (1) US4758657A (da)
EP (1) EP0209041A3 (da)
JP (1) JPS6219534A (da)
AU (1) AU6001586A (da)
DK (1) DK332086A (da)
ES (1) ES2000030A6 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5043428A (en) * 1984-08-31 1991-08-27 Behringwerke Aktiengesellschaft Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production
JP2872255B2 (ja) * 1987-01-30 1999-03-17 バイオジエン，インコーポレイティド ファクター▲ｖｉｉｉ▼の高収量生産法
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
US5605884A (en) * 1987-10-29 1997-02-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Factor VIII formulations in high ionic strength media
ATE112287T1 (de) * 1987-12-21 1994-10-15 Miles Inc Faktor viii- gelfiltration.
DK162233C (da) * 1989-11-09 1992-03-16 Novo Nordisk As Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii
FR2681867B1 (fr) * 1991-09-26 1993-12-31 Pasteur Merieux Serums Vaccins Procede de purification du facteur viii et preparations obtenues.
DE69333928T2 (de) * 1992-04-30 2006-08-17 Probitas Pharma Inc., Los Angeles Verbesserte solubilisierung und stabilisierung des faktor viii-komplexes
US5288853A (en) * 1992-04-30 1994-02-22 Alpha Therapeutic Corporation Factor viii purification process
WO1994007510A1 (en) * 1992-10-02 1994-04-14 Kabi Pharmacia Ab Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer
AU7254894A (en) * 1993-07-23 1995-02-20 Baxter International Inc. Activated human factor viii and method of preparation
US5576291A (en) * 1993-09-13 1996-11-19 Baxter International Inc. Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency
SE503424C2 (sv) * 1994-11-14 1996-06-10 Pharmacia Ab Process för rening av rekombinant koagulationsfaktor VIII
GB9501040D0 (en) * 1995-01-19 1995-03-08 Quadrant Holdings Cambridge Dried composition
US7244824B2 (en) * 1995-01-19 2007-07-17 Quadrant Drug Delivery Limited Dried blood factor composition comprising trehalose
US7253262B2 (en) * 1995-01-19 2007-08-07 Quandrant Drug Delivery Limited Dried blood factor composition comprising trehalose
US5925738A (en) * 1995-12-01 1999-07-20 The American National Red Cross Methods of production and use of liquid formulations of plasma proteins
US6632648B1 (en) 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
US5763401A (en) * 1996-07-12 1998-06-09 Bayer Corporation Stabilized albumin-free recombinant factor VIII preparation having a low sugar content
FR2772381B1 (fr) † 1997-12-15 2001-06-08 Lab Francais Du Fractionnement Procede de preparation par filtration d'une solution de facteur viii securisee viralement
CA2634663C (en) 1999-02-22 2009-08-25 University Of Connecticut Novel albumin-free factor viii formulations
EP2385825B1 (en) 2008-11-07 2018-10-10 University of Connecticut Factor viii formulations
NZ601339A (en) * 2009-01-26 2013-09-27 Burcon Nutrascience Mb Corp Production of soluble soy protein products

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069216A (en) * 1975-06-16 1978-01-17 Edward Shanbrom, Inc. Simplified methods for preparation of very high purity Factor VIII concentrate
US4314997A (en) * 1980-10-06 1982-02-09 Edward Shanbrom Purification of plasma protein products
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4673733A (en) * 1985-04-11 1987-06-16 Sudhish Chandra Treatment of biological and pharmaceutical products adsorbed on a solid phase with virus and pyrogen inactivating agents

Also Published As

Publication number Publication date
JPS6219534A (ja) 1987-01-28
ES2000030A6 (es) 1987-10-01
EP0209041A3 (en) 1989-03-22
US4758657A (en) 1988-07-19
DK332086A (da) 1987-01-12
AU6001586A (en) 1987-01-15
EP0209041A2 (en) 1987-01-21

Similar Documents

Publication Publication Date Title
DK332086A (da) Fremgangsmaade til rensning af faktor viii.c og farmaceutisk middel indeholdende faktor viii.c
DK83388D0 (da) Farmaceutisk middel indeholdende den insulin-lignende vaekstfaktor ii (igf-ii) til topisk anvendelse til saarheling
DK531885D0 (da) Fremgangsmaade til desinfektion og middel dertil
DK330287D0 (da) Antiinflammatorisk forbindelse og farmaceutisk sammensaetning indeholdende samme
DK331488A (da) Middel og fremgangsmaade til oprensning af faktor viii c
DK448686D0 (da) Fremgangsmaade til rensning af antihemofil faktor
DK162445C (da) Pyranopyridiner, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende pyranopyridinerne
DE3678356D1 (de) Fluessige shampoozusammensetzung.
FI862479L (fi) Oral farmaceutisk komposition.
DK183589A (da) Farmaceutisk middel indeholdende en 12-leddet macrolid-forbindelse og fremgangsmaade til fremstilling heraf
DE3684967D1 (de) Fluessigkristallzusammensetzung.
DE3866376D1 (de) Cyclohexanabkoemmling und ihn enthaltende fluessigkristallzusammensetzung.
DK40986D0 (da) 4h-1-benzopyran-4-oner og deres svovlholdige analoge, og farmaceutiske kompositioner indeholdende forbindelserne
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
DK271487D0 (da) Beholder og emne til fremstilling heraf
DK114592A (da) Silibininholdigt farmaceutisk middel
DK160150C (da) Benzothiazinderivater, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende samme
DE3578422D1 (de) 3-substituierte carbacephem-verbindung und sie enthaltende pharmazeutische zusammensetzung.
IT1213453B (it) Composizione farmaceutica.
DK163285D0 (da) 4-hydroxy-2h-1-benzothiopyran-2-on-forbindelser og fremgangsmaade til fremstilling deraf samt rodenticidt middel
NO860733L (no) N-(2-klor-4-trifluormethylfenyl)-3-trifluormethyl-benzensulfonamidderivat, fremgangsmaate for fremstilling av dette, og fungicid middel inneholdende dette.
DK133587D0 (da) 2-heterocyclylthio-penemer, deres anvendelse og farmaceutisk komposition indeholdende forbindelserne
DK164865C (da) Silibininderivater, fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende silibininderivaterne
FI874414A0 (fi) Kontrollerat frigoerande farmaceutiska kompositioner.
DK632388D0 (da) Pharmaceutisk middel til behandling af hypolipidaemi hos pattedyr

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment